MiR-135a-5p represses proliferation of HNSCC by targeting <i>HOXA10</i>.

Guo, Lei-Ming; Ding, Gao-Feng; Xu, Wencai; Ge, Hong; Jiang, Yue; Chen, Xi-Juan; Lu, Yufei

MiR-135a-5p represses proliferation of HNSCC by targeting HOXA10.

Guo, Lei-Ming; Ding, Gao-Feng; Xu, Wencai; Ge, Hong; Jiang, Yue; Chen, Xi-Juan; Lu, Yufei.

Afiliación

Guo LM; a Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.
Ding GF; a Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.
Xu W; a Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.
Ge H; a Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.
Jiang Y; a Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.
Chen XJ; a Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.
Lu Y; a Department of Radiotherapy , Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital , Zhengzhou 450000 , Henan , China.

Cancer Biol Ther ; 19(11): 973-983, 2018.

Article en En | MEDLINE | ID: mdl-29580143

Palabras clave

HNSCC; miR-135a-5p; miR-494

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancer Biol Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google